HomeInsightsStock Comparison

Mangalam Drugs And Organics Ltd vs Strides Pharma Science Ltd Stock Comparison

Mangalam Drugs And Organics Ltd vs Strides Pharma Science Ltd Stock Comparison

Last Updated on: Jul 22, 2025

Key Highlights

  • The Latest Trading Price of Mangalam Drugs and Organics Ltd is ₹ 89.96 as of 22 Jul 12:22.
  • The P/E Ratio of Mangalam Drugs and Organics Ltd changed from 0 on March 2020 to 0 on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Strides Pharma Science Ltd changed from 79.4 on March 2020 to 1.7 on March 2025 . This represents a CAGR of -47.30% over 6 years.
  • The Market Cap of Mangalam Drugs and Organics Ltd changed from ₹ 146.65 crore on March 2024 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 2 yearsThe Market Cap of Strides Pharma Science Ltd changed from ₹ 2888 crore on March 2020 to ₹ 6165 crore on March 2025 . This represents a CAGR of 13.47% over 6 years.
  • The revenue of Mangalam Drugs and Organics Ltd for the Mar '25 is ₹ 73.25 crore as compare to the Dec '24 revenue of ₹ 88.85 crore. This represent the decline of -17.56% The revenue of Strides Pharma Science Ltd for the Mar '25 is ₹ 1205 crore as compare to the Dec '24 revenue of ₹ 1160 crore. This represent the growth of 3.9%.
  • The ebitda of Mangalam Drugs and Organics Ltd for the Mar '25 is ₹ 10.37 crore as compare to the Dec '24 ebitda of ₹ 8.91 crore. This represent the growth of 16.39% The ebitda of Strides Pharma Science Ltd for the Mar '25 is ₹ 205.56 crore as compare to the Dec '24 ebitda of ₹ 214.45 crore. This represent the decline of -4.15%.
  • The net profit of Mangalam Drugs and Organics Ltd changed from ₹ 0.5 crore to ₹ 0.06 crore over 6 quarters. This represents a CAGR of -75.67% The net profit of Strides Pharma Science Ltd changed from ₹ -9.36 crore to ₹ 85.62 crore over 8 quarters. This represents a CAGR of NaN% .
  • The Dividend Payout of Mangalam Drugs and Organics Ltd changed from 0 % on March 2020 to 0 % on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Strides Pharma Science Ltd changed from 104.26 % on March 2020 to 1.28 % on March 2025 . This represents a CAGR of -51.97% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Mangalam Drugs and Organics Ltd

  • Mangalam Drugs and Organics Ltd was formerly incorporated on April 18, 1972 as a private limited company with the name Advent Pharma Pvt Ltd. On July 1, 1997, the Company changed their name from Advent Pharma Pvt Ltd to Mangalam Drugs and Organics Pvt Ltd. Thereafter, the Company converted into a Public Limited Company and name of the Company was changed from Advent Pharma Ltd to Mangalam Drugs and Organics Ltd on August 10, 2001.
  • The company was promoted by Dhoot family.
  • The company was established with a view to set up a plant for manufacture of organic and inorganic chemicals. The company is engaged in the manufacturing of chemicals, such as active pharma ingredients (API) perfumery, disperse dye intermediates, bulk drugs and bulk drugs intermediates.
  • The company has their manufacturing facilities at Vapi in Gujarat and Sangamner in Maharashtra.

About Strides Pharma Science Ltd

  • Strides Pharma Science Limited was originally incorporated under the name 'Strides Arcolab Limited ' on June 28, 1990.
  • In FY 2016, Shasun Pharmaceuticals Limited merged with Strides Arcolab Limited forming a new identity 'Strides Shasun Limited', making it effective from 19 November, 2015 and name of the Company was changed to 'Strides Pharma Science Limited' from 'Strides Shasun Limited' effective on July 18, 2018. Strides Pharma Science is a global pharmaceutical company headquartered in Bengaluru, India.
  • The Company is an integrated manufacturer and exporter of Finished Pharmaceutical Dosage forms for both branded and generic.
  • It manufactures a very wide spectrum of ethical pharmaceutical products, OTC products and nutraceuticals.
  • Their dosage forms range includes tablets, capsules, soft gelatin capsules, parenterals and semisolids.

Mangalam Drugs and Organics Ltd News Hub

News

Mangalam Drugs and Organics schedules EGM

Mangalam Drugs and Organics announced that an Extra Ordinary General Meeting (EGM) of the ...

Read more

14 Jul 2025 10:27

News

Mangalam Drugs and Organics announces board meeting date

Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company o...

Read more

15 May 2025 15:37

News

Mangalam Drugs and Organics to conduct board meeting

Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company o...

Read more

05 Apr 2025 10:36

News

Mangalam Drugs and Organics to convene board meeting

Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company o...

Read more

06 Feb 2025 16:48

News

Mangalam Drugs and Organics receives upgrade in credit ratings from CRISIL

Mangalam Drugs and Organics has received upgrade in credit ratings from CRISIL as under: L...

Read more

16 Jan 2025 14:54

News

Mangalam Drugs and Organics Ltd leads gainers in 'B' group

Soma Textiles & Industries Ltd, Saraswati Saree Depot Ltd, Pudumjee Paper Products Ltd and...

Read more

29 Nov 2024 12:15

Strides Pharma Science Ltd News Hub

News

Strides Pharma Science schedules AGM

Strides Pharma Science announced that the 34th Annual General Meeting(AGM) of the company ...

Read more

10 Jul 2025 10:16

News

Board of Strides Pharma Science recommends final dividend

Strides Pharma Science announced that the Board of Directors of the Company at its meeting...

Read more

22 May 2025 18:03

News

Strides Pharma Science to announce Quarterly Result

Strides Pharma Science will hold a meeting of the Board of Directors of the Company on 22 ...

Read more

17 May 2025 11:40

News

Strides Pharma's US arm acquires four drugs to bolster portfolio

The portfolio consists of liquids and immediate release solid orals which are in the thera...

Read more

30 Apr 2025 07:51

News

Strides Pharma Science announces incorporation of step-down subsidiary

Arco Lab, a wholly owned subsidiary of Strides Pharma Science has incorporated a new wholl...

Read more

11 Apr 2025 15:34

News

Strides Pharma Science announces acquisition of Singapore-based Amexel

Strides Pharma Global (SPG), a step-down wholly-owned subsidiary of Strides Pharma Science...

Read more

15 Mar 2025 15:45

SWOT Analysis Of Strides Pharma Science Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Mangalam Drugs and Organics Ltd

Strength

2

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Strides Pharma Science Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Mangalam Drugs and Organics Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Mangalam Drugs and Organics Ltd and Strides Pharma Science Ltd

Which company has a larger market capitalization, Mangalam Drugs and Organics Ltd or Strides Pharma Science Ltd?

Market cap of Mangalam Drugs and Organics Ltd is 143 Cr while Market cap of Strides Pharma Science Ltd is 8,199 Cr

What are the key factors driving the stock performance of Mangalam Drugs and Organics Ltd and Strides Pharma Science Ltd?

The stock performance of Mangalam Drugs and Organics Ltd and Strides Pharma Science Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Mangalam Drugs and Organics Ltd and Strides Pharma Science Ltd?

As of July 22, 2025, the Mangalam Drugs and Organics Ltd stock price is INR ₹90.79. On the other hand, Strides Pharma Science Ltd stock price is INR ₹889.65.

How do dividend payouts of Mangalam Drugs and Organics Ltd and Strides Pharma Science Ltd compare?

To compare the dividend payouts of Mangalam Drugs and Organics Ltd and Strides Pharma Science Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions